Chromosomal region 11q22-q23 is a frequent target for deletion during the development of many solid tumour types, including breast, ovary, cervix, stomach, bladder carcinomas and melanoma. One of the most commonly deleted subregions contains the SDHD gene, which encodes the small subunit of cytochrome b (cybS) in mitochondrial complex II (succinate-ubiquinone oxidoreductase). Germline mutations in SDHD cause hereditary paraganglioma type 1 (PGL1), and suggest a tumour suppressor role for cybS. We present a high-resolution physical map spanning SDHD, covered by 19 YACs and 20 BACs. An approximate 1.1-Mb gene-rich region around SDHD is spanned by a complete BAC contig. Twenty-six new STSs are developed from the BAC clone ends. In addition to the discovery and characterisation of 15 new simple tandem repeat polymorphisms, we provide integrated positional information for 33 ESTs and known genes, including KIAA1391, POU2AF1 (OBF1), PPP2R1B, CRYAB, HSPB2, DLAT, IL-18, PTPS, KIAA0781 and KAIA4591, which is mapped by NotI site cloning. We describe full-length transcript sequence for PPP2R1B, encoding the protein phosphatase 2A regulatory subunit A beta isoform. We also discover a processed pseudogene for USA-CYP, a cyclophilin associated with U4/U6 snRPNs, and a novel gene, DDP2, encoding a mitochondrial protein similar to the X-linked deafness-dystonia protein, which is juxtaposed 5'-to-5' to SDHD. This map will help assess this gene-rich region in PGL and in other common tumours.
Introduction
Somatic deletions in the chromosomal region 11q22-q23 are frequent for many tumour types, including breast, ovary, cervix, stomach, bladder carcinomas and melanoma. 1 These deletions map to several non-overlapping sub-regions, thus revealing potential sites harbouring tumour suppressor activity. Because a 6 Mb interval between D11S2000 and D11S897 is one of the most frequently deleted sub-regions in these common tumours, it may harbour either several distinct tumour suppressor genes or a single gene of fundamental importance to the process of neoplasia. In fact, several candidate tumour suppressor genes are located into this region. Germ-line mutations in ATM cause ataxia-telangiectasia (AT). 2 AT patients have a predisposition
to malignancies, such as B-cell lymphomas and T-cell leukaemias; however, the role of ATM as a tumour suppressor gene in solid tumours is controversial. 3 Somatic mutations involving PPP2R1B, which encodes a protein phosphatase 2A subunit, have been identified in a small fraction of common tumours that show regional loss-of-heterozygosity (LOH). 4, 5 Whether PPP2R1B serves a tumour suppressor role at the cellular level remains to be established. 6 Finally, SDHD encodes the small subunit of the cytochrome b (cybS) in mitochondrial complex II (succinate-ubiquinone oxidoreductase). 7, 8 Germline mutations in SDHD cause hereditary paraganglioma type 1 (PGL1), a rare disorder characterised by the development of mostly benign, highly vascular tumours in the head and neck. 9 PGL tumours develop in an autosomal dominant pattern after paternal transmission of the mutant gene, whereas no phenotype occurs after maternal transmission, suggesting that SDHD is subject to genomic imprinting. 10 The germline loss-of-function mutations in the paternal alleles and the subsequent somatic loss of normal maternal alleles in PGL tumours define a tumour suppressor role for SDHD. Based on the phenotypic similarity between the PGL tumours and the CB's response to chronic hypoxic exposure, we have hypothesised that loss of SDHD compromises oxygen sensing and leads to tumour development in the paraganglionic tissues. Because it has been postulated that hypoxic environment provides a selective pressure towards more aggressive phenotypes in solid tumours, 11 it is conceivable that loss of SDHD could play a wider role in common tumorigenesis. We present a high-resolution physical map around SDHD to help refine minimal critical regions of LOH at 11q23 in common tumours and to facilitate assessment of candidate tumour suppressor genes. This map contains an overlapping set of small-insert-YAC and BAC clones, as well as large-insert CEPH mega-YACs across a 3 Mb region, and provides integrated physical information for 33 ESTs/known genes and 15 new (CA)n simple tandem repeat polymorphisms (STRPs).
Materials and methods
EST/STS content mapping, BAC library screening, insert analysis, and identification of vector end sequences EST/STS content mapping was performed using standard PCR amplification as described elsewhere. 12 We initially selected Selected bands were isolated from agarose gels using commercial protocol (Quiaex II gel purification kit, Qiagen), and sequenced from both directions with a linker specific primer and the relevant (CA)n-NN primer. Based on the new sequence identified from one side of the (CA)n, a unique reverse primer was designed and bubble-vectorette libraries amplified through the (CA)n repeat to obtain sequence from the other side of the repeat. Heterozygosities for the new repeats were assessed by polyacrylamide gel (6%) electrophoresis, using PGEM3zf/-40 sequencing reaction products as a molecular weight marker. SNPs were identified by single strand conformational polymorphism (SSCP) analysis and sequencing. All DNA sequencing reactions were performed by ABI 373A version 1.2.0 fluorescent sequencer, as described by the manufacturer.
Cloning NotI sites To identify NotI sites, regional BAC clones were isolated and subjected to Pulsed Field Gel Electrophoresis (PFGE) after NotI digestion. A panel of 4 bp-frequent cutter enzymes, including RsaI, HaeIII, AluI, Sau3AI, were used to digest the BAC clones containing NotI sites and the products were ligated to plasmid vector pBlueScript SK-(Stratagene), which had been digested with SmaI (for blunt end fragments) and BamHI (for Sau3AI). The ligated molecules were subcloned into XL-1 Blue bacterial host by electroporation (GenePulser, BioRad). Then the transformants were double-digested with NotI/ EcoRI and analysed for inserts using standard methodology. The plasmids containing NotI inserts were partially sequenced and subjected to BLAST analysis to identify nucleotide matches. 
PPP2R1B 3'-UTR characterisation

Results
Contig construction and STS mapping
To nucleate a physical map in the region between D11S1986 and D11S1347, the last published borders bracketing PGL1 prior to its cloning, we selected a set of STSs, ESTs, CEPH mega-and RPCI small-insert YACs obtained from either Figure 1 Contig of large-insert CEPH mega-YACs, and small-insert RPCI YACs. The contig spans more than 3-Mb. The insert sizes of the clones are depicted in parenthesis. Genes, ESTs, STRPs (shown with @ extension), and non-polymorphic STSs are localised to distinct intervals defined by clone overlaps. genome-wide or previous regional mapping data. This initial map provided full mega-and small-insert YAC-contigs spanning the PGL1 critical region (Figure 1 ). This map located D11S1986 approximately 1 Mb centromeric to D11S1347, less than originally estimated based on other regional maps. 19 Our analysis showed D11S1986 is an expressed STRP derived from the 3'-untranslated region of POU2AF1 (OBF1), which encodes the B-cell octamer binding factor. 20 Using these initial YAC contig data, we selected several ESTs and STSs for PCR-screening of BAC library pools. New STSs were created from BAC insert ends and used to confirm their regional localisation and to determine clone overlap patterns. After many rounds of BAC end sequencing and library screening, a BAC contig composed of 20 BACs, including three BACs detected in the TIGR database, were constructed ( Figure 2 ). The BAC contig spanned approximately 1.1 Mb. The insert sizes and NotI restriction sites of each BAC were analysed by PFGE, uncovering the presence of three NotI sites in the region, consistent with a previous regional NotI map. 21 To create new STSs, the insert-ends of 15 selected clones were sequenced. Of the 27 STSs created, 26 mapped back to the clones from which they were derived and to other regional clones. The STS derived from the SP6-end of B103-G-1 did not map back to other regional clones, thus implying potential chimerism in this BAC. Some insert ends contained expressed sequences as detected by BLAST analysis. These expressed sequences included POU2AF1 (OBF1), 22 IL-18, encoding interleukin 18, 23 and a novel processed pseudogene Open and closed boxes at the end of BACs denote the SP6-and T7-insert-ends, respectively. BACs B2371L7, R-18C15 and B2329O11 are identified in the TIGR database by searching with a genomic sequence containing SDHD. The pDJ159O1 box shows the location of a previously characterized PAC clone 34 and the five STRPs used in the repositioning of the PGL1 critical region. 19 Two of the STRPs, D11S5011 and D11S5019, have been previously described. 9 The arrows underlying some genes depict their 5'-to-3' orientation. dbEST numbers are used to label ESTS.
for USA-CYP, encoding a cyclophilin associated with U4/U6 snRPNs. 24, 25 Complete sequencing of the USA-CYP pseudogene revealed that it is 92% identical to the USA-CYP mRNA sequence, lacks introns, contains in-frame premature stop codons, and is followed by a poly(A) sequence. These features strongly suggest this pseudo-gene has arisen by retrotransposition of USA-CYP mature RNA.
Fluorescent in situ hybridisation (FISH) analysis
To confirm BAC overlap patterns, seven clones, B308-E-17, B278-J-1, B519-J-1, B285-I-24, B36-P-5, B348-O-11, and B312-D-17, were selected from the BAC contig. None of these clones was found to be chimaeric in metaphase FISH (data not shown). The order and orientation of these clones in the BAC contig, which had been determined by STS-based 
Identification of novel (CA)n STRP and SNP
To search for novel (CA)n repeats, several BACs were selected. Using a PCR-based approach, three to four (CA)n sequences Figure 3 Fiber-FISH mapping of seven 11q23 BACs. Two or three examples of fluorescent signals from each pair of BACs, which have been labelled in red and green, confirm their order as shown in the contig underneath. The overlap between the BAC pairs B308-E-17 and B278-J-1, B285-I-24 and B36-P-5 and B348-O-11 can clearly be observed as a yellow signal. In case of overlap, the signal from each BAC is also shown separately.
European Journal of Human Genetics
An integrated map spanning the SDHD gene at 11q23 BE Baysal et alper BAC were identified. Sequences were first assessed for the number uninterrupted CA repeats, on the assumption that the degree of polymorphism would be proportional to the repeat number. Loci having less than 8 CA repeats were not evaluated further. On one occasion, however, captured sequences revealed a (TA)n motif, which proves to be a highly polymorphic locus (D11S5004). Thirteen of the new STRPs had heterozygosities larger than 0.5, as determined by analysing a number of unrelated Caucasian chromosomes (Table 1 ). SSCP analysis of regional genes revealed four new coding region SNPs; a synonymous and a non-synonymous SNP in CRYAB, a synonymous SNP in HSP2, and a 3'-UTR SNP in KIAA0781.
Transcript mapping
Gene/EST mapping showed a high transcript density in the region, and provided relative locations of KIAA1391, POU2AF1 (OBF1), PPP2R1B, CRYAB, HSPB2, DLAT, IL-18, PTPS, KIAA0781 and KAIA4591. While a number of ESTs clustered to the centromeric third of y755-b-11 (Figure 1 ), their order could not be established in the absence of smallinsert clones covering that region. KIAA1391, a novel gene that mapped in a region frequently deleted in B-cell chronic lymphocytic leukaemia, 26 shows strong homology to a chromosome X-linked rho-GTPase-activating protein predominantly expressed in haematopoietic cells. 27 Several ESTs in databases, including EST222225 (D11S966E), derived from KIAA0781, a large transcript encoding a novel serine-threonine kinase. 28 By mapping KIAA0781-derived amplicons in the contig, we found this gene to be oriented 5'-centromeric to 3'-telomeric, with its 3'-end located only 10 kb from the 3'-end of PPP2R1B (data not shown) (Figure 2 ). In addition to SDHD and DLAT, EST274275, EST198329, EST229158, and D11S2246E mapped to BAC B312-D-17. By BLAST analysis, all three ESTs clustered to an approximate 29 kb genomic sequence (GenBank accession number AB026906) containing the exons for SDHD: while EST198329 and EST229158 map immediately 5' to SDHD, D11S2246E, which is mostly composed of repeat sequences, is derived from SDHD intron 3. Further database analysis revealed that EST198329 is derived from DDP2, encoding a protein similar to the mitochondrial protein DDP of X-linked deafness dystonia syndrome and that EST229158 was derived 18 5'-GGAAGGAGAAGAGGAAATGCT-3' 5/0.62/36 D11S5009 B264J16CA-GT2 B264J16 5'-ATCATGCACCAAGAGAAGTAC-3' 126 ± 140 bp (CA) 16 5'-CTTTAGTAGTCTATCGTCTATCT-3' 3/0.52/31 D11S5010 B519J1CA-A a B519J1 5'-AGCTGGGAGTACAGGTGTG-3' 212 ± 220 bp (CA) 14 5'-CTCAGTTTTCTAATACTCTATTGA-3' 5/0.76/65 D11S5012 B519J1CA-C B519J1 5'-GCACTCCTATGTTCATTACAG-3' 185 ± 197 bp (CA) 18 5'-GTTTCATATGGCAGGAGTCC-3' 6/0.73/34 D11S5013 B247A4CA-A B247A4 5'-AAACGCAGCAAGACCCTGTT-3' 140 ± 158 bp (CA) 10 5'-AGGGGTTCATGACCATCCTA-3' 3/0.11/45 D11S5014 B247A4CA-F B247A4 5'-GTCTCTCCAAGTTGGGTAGTA-3' 138 ± 162 bp (CA) 12 5'-ATAGGCATGTGCCACCACAT-3' 6/0.79/33 D11S5015 B348O11CA-A B348O11 5'-GCAACTCAAGAGCCCATCAA-3' 147 ± 172 bp (CA) 20 5'-CCATGTTGTAGCATGTGACA-3' 8/0.79/23 D11S5016 B348O11CA-C B348O11 5'-GTTCCTGCTACTGTTCTCCA-3' 144 ± 154 bp (CA) 20 5'-TTATGGAGATGAGACCAGACTA-3' 6/0.66/45 D11S5017 B348O11CA-D B348O11 5'-GCGTATGCATGCGCTTGCA-3' 136 ± 148 bp (CA) 17 5'-GGCCGTTTGTGGCCTTAAGT-3' 7/0.61/42 D11S5018 B312D17CA-AC B312D17 5'-CTTTCTGGCTCGTAGCCGTA-3' 240 ± 244 bp (CA) 12 5'-TGAATGAGGAAACGATCATAGA-3' 2/0.26/35 D11S5020 PPP2R1B PPP2R1B 5'-TCCCACTGTTGCTGAGACAT-3' 134 ± 146 bp 5'->CATCCTTGGCAGCTTACATCA-3' 7/0.78/45 a A null allele is observed for D11S5010.
An integrated map spanning the SDHD gene at 11q23 BE Baysal et al 126 from a distinct gene with no detectable homology (GenBank accession number AK001588). The analysis of DDP2 (GenBank accession numbers AF150087, AF165967) and SDHD (GenBank accession number NM_003002) transcripts in Genbank database revealed that the two genes are oppositely oriented and that their transcription start sites were separated by less than 150 bp.
NotI site cloning
Because most NotI sites in the human genome mark CpG islands that are associated with expressed sequences, 29 we attempted to clone the NotI sites in this region of 11q23. We cloned and sequenced two of the three sites, NotI-C and NotI-B (Figure 2) , identified in the BAC contig. Sequences derived from both NotI sites mapped back to the regional clones by hybridisation and PCR amplification. BLAST analysis of the sequences around the NotI sites identified unmapped EST sequences. The sequence of 5'-
flanked the NotI-C site (underlined) and identified a complete match (in bold) to several ESTs similar to alpha actinin (for example GenBank accession number AW297566). The sequence of 5'-ACTTCGCTGTGGTGAAGCTGGGGCGGCACCGGATCAC-
GAGCGTCCGAGGCGAGGGTTCGGGAGAGGAGCTGCT-TACCGAGAGGGGCGGCCGC-3' flanked the NotI-B site (underlined) and identified a complete match (in bold) to cDNA clone KAIA4591 (GenBank accession number AK000396), which also showed significant sequence overlap with the 5'-region of KIAA0781 (above). These data suggest that 5'-end of KIAA0781 spans the NotI-B site which is located at least 100-kb centromeric from its 3'-end (Figure 2 ).
Full characterisation of PPP2R1B transcript PP2R1B has two major transcript isoforms on Northern analysis, 2.5 and 5.0 kb.
14 cDNA sequences compatible with the 2.5 kb transcript have been previously identified. By EST mapping, cDNA clone sequencing and database search, we obtained a 5.6 kb cDNA sequence and showed that the larger transcript arises by alternative polyadenylation signal usage. The extended 3'-UTR sequence of PPP2R1B also revealed a novel (CA)n STRP, D11S5020, which is highly polymorphic ( Table 1) . By RT ± PCR experiments, we confirmed the newlyidentified sequence derives from the 3'-UTR of PPP2R1B, it is not interrupted by an intron at the genomic level and that D11S5020 is an expressed STRP (data not shown). The complete 5.6 kb PPP2R1B sequence has been deposited to GenBank under accession number AF163473. Finally, to test whether positions of most PPP2R1B EST 3'-ends would be compatible with either 2.5 kb or 5.0 kb sizes observed in Northern analysis, we mapped the ends of 3'- Figure 4 Summary of the characteristics of PPP2R1B 3'-UTR. The vertical arrowhead denotes the stop codon at nt 1873. 14 The horizontal bars below the cDNA scale denote sources of sequences initially used to assemble the 3'-UTR sequence and filled circles denote 3'-ends of matching EST sequences in GenBank. Each filled semi-circle corresponds to a single EST sequence. Poly(A) signal motifs preceding the transcript ends are shown on top. Most of 3'-ends are located after the first consensus Poly(A) signal positioned at the end of a LINE repeat sequence. Alu repeat and (CA)n sequences are also shown. The numbering of the cDNA shown on the scale follows the one used in Baysal et al.
PPP2R1B-derived EST sequences in GenBank EST database onto the 5.6 kb transcript sequence. The 3'-ends of EST clones cluster in two regions (Figure 4 ): 33% between nt 2050 ± nt 2650, and 59% between nt 4290 ± nt 2630. Thus, with added Poly(A) tails, these transcript sizes approximated the observed major band sizes in the Northern analysis. All mapped EST clones had either the consensus polyadenylation signal, 5'-AATAAA-3', or one of its single nucleotide neighbours within 75 bp of termination. 30 Almost half of the EST ends (48%) mapped following the first consensus polyadenylation signal at nt 4272. Interestingly, this major consensus signal occurs within a long interspersed repeat element, LINE2, and adds PPP2R1B to the growing number of genes that utilise repetitive elements for transcript polyadenylation. 31 
Discussion
First draft genomic sequences are now available for many chromosomal regions through the multi-nationally sponsored Human Genome Project. However, until ordered, gapfree and fully-annotated genomic sequences are available for each chromosome, high-resolution, informative physical maps, especially in regions of biological interest, should continue to be useful by complementing raw sequence data. Three mega-YAC-based physical maps spanning this region of chromosome 11q23 have been previously reported, 21, 32, 33 however they do not provide detailed coverage for the interval presented in this study. The abundance of transcripts and the presence of three NotI sites within an approximate 1.1-Mb interval indicate a gene-rich genomic domain around the SDHD gene. Partial sequence data from a PAC clone pDJ159O1 that maps within this region also confirms high transcript density. 34 The abundance of transcripts is consistent with the presence of distinct tumour suppressor genes for different tumour types, although a single tumour suppressor gene fundamentally important to neoplastic transformation cannot be ruled out. The mapped transcripts already suggest several candidate tumour suppressor genes. For example, KIAA1391 and POU2AF1 (OBF1) map on mega-YAC y755-b-11, which is frequently deleted in B-cell chronic lymphocytic leukaemia. 26 KIAA0781, a large novel serine-threonine kinase, is localised immediately centromeric to PPP2R1B. This map also reveals that PPP2R1B and SDHD are separated by only 250 kb. Thus large somatic deletions spanning this region cannot be informative regarding targeted gene(s); instead, identification of intragenic deletions and/or mutations will be necessary to evaluate each gene. The high density of genes within the BAC contig is also reflected by the noteworthy proximity. For example, CRYAB and HSPB2 are oriented 5'-to-5' within less than a 1-kb intergenic interval, and they potentially share some regulatory elements. 35 A similar mechanism of coordinated gene expression may also operate for SDHD and DDP2, which show immediate 5'-to-5' organisation.
Our discovery of 15 new STRPs brings their total number to 24 within the 1.1-Mb interval spanned by the BAC contig, including two STRPs within 400-kb of the SDHD gene 9 and five STRPs derived from regional PAC clone pDJ159O1. 19 The high intensity of STRPs provides a powerful tool for the evaluation of new PGL families for linkage and haplotype analyses, as well as for the assessment of PGL and other tumour types for somatic deletions. If certain alleles of the newly characterised, expressed dinucleotide repeat at PPP2R1B, D11S5020, affect mRNA stability, they may be associated with higher risk of tumorigenesis. Finally, although the inheritance of the disease phenotype in PGL1 is determined strictly by the sex of the transmitting parent, previous work on SDHD showed no evidence for imprinting. 9 The resources developed herein may also be useful to determine the precise mechanism of the parent-specific transmission in PGL1.
